Related Experiment Videos

Lung isolation in a child with unilateral necrotizing Clostridium perfringens pneumonia

Ken M Brady1, Z Leah Harris, Gregory B Hammer

  • 1Department of Anesthesiology/Critical Care Medicine and Pediatrics, Johns Hopkins Hospital, Baltimore, MD, USA.

Critical Care Medicine
|November 9, 2005
PubMed

Insights

This case report details using an endobronchial blocker for lung isolation and selective continuous positive airway pressure in a pediatric patient with severe necrotizing pneumonia. This novel approach successfully aerated the lung, avoiding surgery.

Area of Science:

  • Pediatric critical care medicine
  • Pulmonary medicine
  • Infectious diseases

Background:

  • Sickle cell disease patients are susceptible to severe pulmonary complications, including necrotizing pneumonia.
  • Managing unilateral lung disease in pediatrics can be challenging, especially with airway limitations.

Observation:

  • A 12-year-old male with sickle cell disease developed necrotizing pneumonia in the left lung.
  • Conventional treatments failed to resolve persistent atelectasis, and the patient's airway was too small for standard double-lumen endotracheal tubes.

Findings:

  • An endobronchial blocker was used for lung isolation and selective continuous positive airway pressure (CPAP) to the affected left lung for 48 hours.
  • This intervention led to substantial lung aeration within 48 hours, avoiding the need for lung resection.

Implications:

  • This case highlights a novel and successful application of endobronchial blockers for selective ventilation in pediatric patients with complex airway anatomy.
  • The technique offers a viable alternative to surgical intervention in select cases of severe unilateral pneumonia.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations: